Malignancies Clinical Trials

30 clinical trials for Malignancies across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma — RECRUITING · PHASE1
• IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies — RECRUITING · PHASE1
• Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma — RECRUITING · PHASE2
• A RANDOMIZED PHASE I/II STUDY OF ONIVYDE IN COMBINATION WITH TALAZOPARIB OR TEMOZOLOMIDE IN CHILDREN AND YOUNG ADULTS WITH RECURRENT SOLID MALIGNANCIES AND EWING SARCOMA — RECRUITING · PHASE1
• PRIMARY THROMBOPROPHYLAXIS IN PATIENTS WITH MALIGNANCY AND CENTRAL VENOUS CATHETERS: A RANDOMIZED CONTROLLED TRIAL (TRIM-LINE) — RECRUITING
• A PHASE I, OPEN-LABEL, MULTI-CENTER STUDY OF SAFETY AND DOSE OF FAZ053 AS SINGLE AGENT AND IN COMBINATION WITH PDR001 IN ADULT PATIENTS WITH ADVANCED MALIGNANCIES — RECRUITING · PHASE1
• A PHASE IIIB/IV SAFETY TRIAL OF FLAT DOSE NIVOLUMAB IN COMBINATION WITH IPILIMUMAB IN PARTICIPANTS WITH ADVANCED MALIGNANCIES — RECRUITING · PHASE3
• 9-ING-41 in Patients With Advanced Cancers — ACTIVE_NOT_RECRUITING · PHASE2
• HELP-STUDY - TOWARDS HIGH THROUGHPUT AND EFFICIENT LONG-AXIAL PET WITH ORAL [18F]FDG — NOT_YET_RECRUITING
• STUDY OF AZD3632 MONOTHERAPY OR IN COMBINATION WITH ANTICANCER AGENTS IN PARTICIPANTS WITH ADVANCED HAEMATOLOGIC MALIGNANCIES WITH KMT2AR, NPM1M, OR OTHER GENOTYPES ASSOCIATED WITH HOX OVEREXPRESSION — NOT_YET_RECRUITING
• Identifying Tissue-of-origin in Transplant Patients and Patients with Malignancies. — ACTIVE_NOT_RECRUITING
• Cancer Therapy-related Cardiac Dysfunction Occuring in Children Treated by Anticancer Drugs for Malignancies — OTHER
• Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers — COMPLETED · PHASE1
• A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies — COMPLETED · PHASE1
• A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies — WITHDRAWN · PHASE1
• A PHASE 2 STUDY OF BRENTUXIMAB VEDOTIN IN COMBINATION WITH PEMBROLIZUMAB IN SUBJECTS WITH METASTATIC SOLID MALIGNANCIES AFTER PROGRESSION ON PRIOR PD-1 INHIBITOR TREATMENT — COMPLETED · PHASE2
• PHASE 1/2 STUDY OF BEMPEGALDESLEUKIN IN COMBINATION WITH NIVOLUMAB IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH RECURRENT OR REFRACTORY MALIGNANCIES (PIVOT IO 020) — NOT_YET_RECRUITING · PHASE1
• A PILOT STUDY ASSESSING THE FEASIBILITY OF A RANDOMIZED CONTROLLED TRIAL INVESTIGATING PRIMARY THROMBOPROPHYLAXIS WITH RIVAROXABAN IN PATIENTS WITH MALIGNANCY AND CENTRAL VENOUS CATHETERS: TRIM-LINE — COMPLETED
• The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. — COMPLETED · PHASE4
• Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Formulations and Doses of PWT-143 — COMPLETED · PHASE1
• A PHASE 1 STUDY OF THE SAFETY AND PHARMACOKINETICS OF VENETOCLAX IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED OR REFRACTORY MALIGNANCIES — COMPLETED · PHASE1
• PHASE 1B MULTI-INDICATION STUDY OF ANETUMAB RAVTANSINE (BAY 94-9343) IN PATIENTS WITH MESOTHELIN EXPRESSING ADVANCED OR RECURRENT MALIGNANCIES — COMPLETED · PHASE1
• Longitudinal Evaluation Study of Vaginal Stenosis With and Without Pelvic Radiation Therapy — COMPLETED
• Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• A PHASE I STUDY OF IDH305 IN PATIENTS WITH ADVANCED MALIGNANCIES THAT HARBOR IDH1R132 MUTATIONS — COMPLETED · PHASE1
• A PHASE 1 OPEN-LABEL, DOSE-ESCALATION, SAFETY AND TOLERABILITY STUDY OF INCB047986 IN SUBJECTS WITH ADVANCED MALIGNANCIES — NOT_YET_RECRUITING · PHASE1
• Study of PWT33597 Mesylate in Subjects With Advanced Malignancies — COMPLETED · PHASE1
• Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies — TERMINATED · PHASE1
• Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma — COMPLETED · PHASE1
• Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component) — COMPLETED · PHASE1

Refine this search